Company Active LTD

Company profile

Biovici Limited

Biovici

Biovici Limited is a UK company with status active founded in 2013 based in Wales.

CRN
08573722
Founded
2013
Age
13

Overview

Legal name
BIOVICI LIMITED
Region
Wales
Registered address
5TH FLOOR LIFE SCIENCE BUILDING 2
SINGLETON PARK
SWANSEA
C&C OF SWANSEA
SA2 8PP
Insolvency history
No

Latest accounts

Financial period: 1 Jul 2024 to 30 Jun 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
2

Company events

Reference milestones and recent Companies House filing stream events.

7 events
29 Mar
2027

Accounts due

Accounts Due

Next accounts due date

02 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

18 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

04 Sep
2024

Gazette Filings Brought Up To Date

Gazette

DISS40 | Transaction MzQzMzY5MDkxOWFkaXF6a2N4 | Paper/PDF filed

Published 05 Sep 2024 06:10

28 Aug
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzMzY5MDkwNGFkaXF6a2N4

Published 28 Aug 2024 21:41

18 Jun
2013

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2015
Funded years
2015, 2017, 2020
Age at first award
1 years

Projects

2020 Collaborative R&D Lead participant

Newton Fund – China-UK Research and Innovation Bridges Competition 2015 Project Title: Graphene biosensor for point of care hepatitis diagnostics - Amendment 3 Extension for Impact

1 Feb 2020 to 31 Dec 2020

Awarded
£9,393
Total cost £13,419

Awaiting Public Project Summary

2017 Collaborative R&D Lead participant

Newton Fund - Graphene biosensor for point of care hepatitis diagnostics

1 Apr 2017 to 30 Sep 2019

Awarded
£153,536
Total cost £219,337

Exceptional electronic properties, surface sensitivity and selectivity, make graphene ideal for sensor applications. Novel, generic, real-time monitoring sensor technology, based on chemically modified graphene channels, will be demonstrated for the detection of salivary / serum hepatitis biomakers. The project will develop an innovative graphene based po...

2015 Collaborative R&D Lead participant

Integration of silicon and printed electronics for sensor applications

1 Mar 2015 to 31 May 2017

Awarded
£53,782
Total cost £89,637

The project will develop an innovative Silicon Nanowire (SiNW) based point-of-care multiplex sensor platform for the early detection of multiple disease biomarkers simultaneously, for the monitoring of chronic conditions. The generic POC platform will enable more efficient & effective healthcare delivery and improved health outcomes for patients. SiNW sen...

Product types

Collaborative R&D